This report was produced throughout the Autumn and Winter of 2020 by the healthcare consulting and analytics company Carnall Farrar. The report received guidance and chairmanship from Professor Sir Mike Richards. The insights, quotes and conclusions contained within the report have been based on detailed interviews with 56 cancer clinicians, academics, executives and managers from within NHS providers, universities and charities. A list of those interviewed can be found in the appendix. This work uses data provided by patients and collected by the NHS as part of their care and support.
The ambition of this report is to highlight the ongoing impact of COVID-19 upon cancer services and cancer patients within the NHS. It recognises that cancer teams across the country have embraced service redesign in many guises to adapt to the new operating environment as part of wider NHS innovation to continue to meet the needs of their patients.
The development, peer review and publication of this report has been commissioned and funded by Roche Products Ltd (UK). Roche has not sought to steer or influence the interviews or the creation of this report in terms of questions asked or themes covered. Roche supports sharing this report to help the NHS improve patient outcomes in cancer.